BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27686345)

  • 1. Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial.
    Rygård SL; Holst LB; Wetterslev J; Winkel P; Johansson PI; Wernerman J; Guttormsen AB; Karlsson S; Perner A; ;
    Intensive Care Med; 2016 Nov; 42(11):1685-1694. PubMed ID: 27686345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower versus higher hemoglobin threshold for transfusion in septic shock.
    Holst LB; Haase N; Wetterslev J; Wernerman J; Guttormsen AB; Karlsson S; Johansson PI; Aneman A; Vang ML; Winding R; Nebrich L; Nibro HL; Rasmussen BS; Lauridsen JR; Nielsen JS; Oldner A; Pettilä V; Cronhjort MB; Andersen LH; Pedersen UG; Reiter N; Wiis J; White JO; Russell L; Thornberg KJ; Hjortrup PB; Müller RG; Møller MH; Steensen M; Tjäder I; Kilsand K; Odeberg-Wernerman S; Sjøbø B; Bundgaard H; Thyø MA; Lodahl D; Mærkedahl R; Albeck C; Illum D; Kruse M; Winkel P; Perner A; ;
    N Engl J Med; 2014 Oct; 371(15):1381-91. PubMed ID: 25270275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion requirements in septic shock (TRISS) trial - comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU: protocol for a randomised controlled trial.
    Holst LB; Haase N; Wetterslev J; Wernerman J; Aneman A; Guttormsen AB; Johansson PI; Karlsson S; Klemenzson G; Winding R; Nebrich L; Albeck C; Vang ML; Bülow HH; Elkjær JM; Nielsen JS; Kirkegaard P; Nibro H; Lindhardt A; Strange D; Thormar K; Poulsen LM; Berezowicz P; Bådstøløkken PM; Strand K; Cronhjort M; Haunstrup E; Rian O; Oldner A; Bendtsen A; Iversen S; Langva JÅ; Johansen RB; Nielsen N; Pettilä V; Reinikainen M; Keld D; Leivdal S; Breider JM; Tjäder I; Reiter N; Gøttrup U; White J; Wiis J; Andersen LH; Steensen M; Perner A
    Trials; 2013 May; 14():150. PubMed ID: 23702006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is haemoglobin below 7.0 g/dL an optimal trigger for allogenic red blood cell transfusion in patients admitted to intensive care units? A meta-analysis and systematic review.
    Yao RQ; Ren C; Zhang ZC; Zhu YB; Xia ZF; Yao YM
    BMJ Open; 2020 Feb; 10(2):e030854. PubMed ID: 32029484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell transfusion during septic shock in the ICU.
    Perner A; Smith SH; Carlsen S; Holst LB
    Acta Anaesthesiol Scand; 2012 Jul; 56(6):718-23. PubMed ID: 22385470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell transfusion in septic shock - clinical characteristics and outcome of unselected patients in a prospective, multicentre cohort.
    Rosland RG; Hagen MU; Haase N; Holst LB; Plambech M; Madsen KR; Søe-Jensen P; Poulsen LM; Bestle M; Perner A
    Scand J Trauma Resusc Emerg Med; 2014 Feb; 22():14. PubMed ID: 24571858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell transfusion strategies in critically ill patients: lessons from recent randomized clinical studies.
    Lelubre C; Vincent JL; Taccone FS
    Minerva Anestesiol; 2016 Sep; 82(9):1010-6. PubMed ID: 26756380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher vs. lower haemoglobin threshold for transfusion in septic shock: subgroup analyses of the TRISS trial.
    Rygård SL; Holst LB; Wetterslev J; Johansson PI; Perner A; ;
    Acta Anaesthesiol Scand; 2017 Feb; 61(2):166-175. PubMed ID: 27910086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogenous treatment effects of transfusion thresholds by patient age: Post-hoc analysis of the TRISS trial.
    Jonsson AB; Granholm A; Rygård SL; Broksø Holst L; Møller MH; Perner A
    Acta Anaesthesiol Scand; 2020 May; 64(5):641-647. PubMed ID: 31885071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients: The Transfusion Requirements in Critically Ill Oncologic Patients Randomized Controlled Trial.
    Bergamin FS; Almeida JP; Landoni G; Galas FRBG; Fukushima JT; Fominskiy E; Park CHL; Osawa EA; Diz MPE; Oliveira GQ; Franco RA; Nakamura RE; Almeida EM; Abdala E; Freire MP; Filho RK; Auler JOC; Hajjar LA
    Crit Care Med; 2017 May; 45(5):766-773. PubMed ID: 28240687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin values, transfusion practices, and long-term outcomes in critically ill patients with traumatic brain injury: a secondary analysis of CENTER-TBI.
    Guglielmi A; Graziano F; Bogossian EG; Turgeon AF; Taccone FS; Citerio G;
    Crit Care; 2024 Jun; 28(1):199. PubMed ID: 38877571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood transfusion practice in critically ill patients: a single institutional experience.
    Al-Faris L; Al-Fares AR; Abdul Malek K; Omran A; Al-Humood S
    Med Princ Pract; 2012; 21(6):560-5. PubMed ID: 22653167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anemia and blood transfusion on clot formation and platelet function in patients with septic shock: a substudy of the randomized TRISS trial.
    Russell L; Holst LB; Lange T; Liang X; Ostrowski SR; Perner A
    Transfusion; 2018 Dec; 58(12):2807-2818. PubMed ID: 30394552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.
    Hajjar LA; Vincent JL; Galas FR; Nakamura RE; Silva CM; Santos MH; Fukushima J; Kalil Filho R; Sierra DB; Lopes NH; Mauad T; Roquim AC; Sundin MR; Leão WC; Almeida JP; Pomerantzeff PM; Dallan LO; Jatene FB; Stolf NA; Auler JO
    JAMA; 2010 Oct; 304(14):1559-67. PubMed ID: 20940381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis*.
    Park DW; Chun BC; Kwon SS; Yoon YK; Choi WS; Sohn JW; Peck KR; Kim YS; Choi YH; Choi JY; Kim SI; Eom JS; Kim HY; Cheong HJ; Song YG; Choi HJ; Kim JM; Kim MJ
    Crit Care Med; 2012 Dec; 40(12):3140-5. PubMed ID: 22975891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.
    Robertson CS; Hannay HJ; Yamal JM; Gopinath S; Goodman JC; Tilley BC; ; Baldwin A; Rivera Lara L; Saucedo-Crespo H; Ahmed O; Sadasivan S; Ponce L; Cruz-Navarro J; Shahin H; Aisiku IP; Doshi P; Valadka A; Neipert L; Waguspack JM; Rubin ML; Benoit JS; Swank P
    JAMA; 2014 Jul; 312(1):36-47. PubMed ID: 25058216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower vs higher transfusion threshold in septic shock patients of different ages: A study protocol.
    Jonsson AB; Granholm A; Rygård SL; Holst LB; Møller MH; Perner A
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1247-1250. PubMed ID: 31281958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trial.
    George EC; Uyoga S; M'baya B; Kyeyune Byabazair D; Kiguli S; Olupot-Olupot P; Opoka RO; Chagaluka G; Alaroker F; Williams TN; Bates I; Mbanya D; Gibb DM; Walker AS; Maitland K;
    Lancet Glob Health; 2022 Mar; 10(3):e360-e368. PubMed ID: 35180419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.